Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Memantine for Enhanced Stroke Recovery
NCT02144584Phase 1Active, not recruiting
- Sponsor
- University of Utah
- Start
- Jan 2014
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in ischemic stroke comparing Placebo plus standard of care with Memantine plus standard of care (2 arms). Primary endpoints: Fugl-Meyer Assessment at 90 days and Adverse events. Started Jan 2014; status: active, not recruiting.
02
Drugs
memantine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02144584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144584.